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ABSTRACT
MACHINE-LEARNING-BASED SEPSIS PREDICTION USING VERTICAL CLINICAL TRIAL DATA:
A NAÏVE APPROACH
by
Tyler Gaddis

The University of Wisconsin – Milwaukee, 2020
Under the Supervision of Jake Luo, PhD

Sepsis is a potentially life-threatening condition characterized by a dysregulated,
disproportionate immune response to infection by which the afflicted body attacks its own
tissues, sometimes to the point of organ failure, and in the worst cases, death. According to
the Centers for Disease Control and Prevention (CDC) Sepsis is reported to kill upwards of
270,000 Americans annually, though this figure may be greater given certain ambiguities in the
current accepted diagnostic framework of the disease.
This study attempted to first establish an understanding of past definitions of sepsis,
and to then recommend use of machine learning as integral in an eventual amended disease
definition. Longitudinal clinical trial data (ntrials=30,915) were vectorized into a machinereadable format compatible with predictive modeling, selected and reduced in dimension, and
used to predict incidences of sepsis via application of several machine learning models: logistic
regression, support vector machines (SVM), naïve Bayes Classifier, decision trees, and random
forests. The intent of the study was to identify possible predictive features for sepsis via
comparative analysis of different machine learning models, and to recommend subsequent
study of sepsis prediction using the training model on new data (non-clinical-trial-derived) in
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the same format. If the models can be generalized to new data, it stands to assume they could
eventually become clinically useful. In referencing F1 scores and recall scores, the random
forest classifier was the best performer among this cohort of models.
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1. INTRODUCTION
Sepsis is a clinical syndrome of exaggerated and life-threatening systemic immune
responses launched by the body against its own tissues on encountering an infection ultimately
resulting in organ damage, organ failure, or death. It is a syndrome comprising myriad
combinations of clinical symptoms in patients suffering from infection, rendering its precise
pathophysiologic definition and subsequent treatment elusive and tenuous at best (Singer et
al., 2016). No single system, pathogen, mediator, or pathway have been isolated as preeminent
drivers of sepsis pathophysiology (Remick, 2007). Sepsis diagnosis is made ambiguous due to its
shared symptoms with other comorbidity pathophysiologies, and modern pervasive use of
antibiotics producing false negative culture results (Vincent, 2016).
The urgency of sepsis and a valid sepsis diagnostic tool is underscored by several facts: that
all of the body’s organ systems are susceptible to it; that the only requirement for sepsis onset
is bacterial, viral, fungal, or parasitic infection; that its frequency is increasing due to an aging
population long benefitting from chronic condition management (here it is hypothesized that
the conditions being managed may be predictive factors for sepsis); that until a 2016 task force
that redefined criteria for sepsis (Sepsis-3), the syndrome definition was over-reliant on
inflammation as its baseline assessment criterion, and on a misguided spectrum model of
disease (Singer et al., 2016); that up to and beyond this task force the definition lacked general
consensus pertaining to its usefulness for clinical diagnosis versus prognosis; that a
demonstrable heterogeneity of inflammatory response and cellular changes in organ tissues of
septic patients exists (Remick, 2007), and thus, that sepsis can initially be clinically
indistinguishable from systemic inflammation from non-infectious causes (Lopansri, Miller, &
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Brandon, 2019); that survivors of sepsis remain susceptible to subsequent chronic physiological,
psychological and cognitive ailments.
Because sepsis represents a relatively common but acute and often lethal clinical syndrome,
continued efforts must be leveraged to identify its precise etiology and pathophysiology. As a
contribution to this effort, this case study attempts to identify predictors for sepsis from a large
clinical trial dataset (n = 30,915) in the form of severe and less-severe adverse events, trial
stage, preexisting conditions, and interventions used for trial health outcomes. If comorbidities
of sepsis are isolated in a large enough sample size, it could be argued that sepsis ought to be
treated according to site-specific biomarkers of, conditions of, and/or proximity to organ
systems where the syndrome develops.

1.1.

RELEVANT SEPSIS STATISTICS

Sepsis represents a significant tax on the American healthcare infrastructure and deserves a
corresponding magnitude of attention. In 2013 alone, sepsis accounted for $24 billion of total
US hospital costs (Paoli et al., 2018). One two-cohort study (Kaiser Permanente Northern
California, n=482,828; Healthcare Cost and Utilization Project Nationwide Inpatient Sample,
n=6,500,000) found that upwards of 50% of all hospital deaths are attributable to sepsis (Liu et
al., 2014).
According to the CDC (Centers for Disease Control and Prevention), 1.7 million American
adults develop sepsis annually, 270,000 of whom die from the disease, amounting to a
mortality rate of nearly 16% (Centers for Disease Control and Prevention, 2020). Sepsis is most
commonly seen in adults aged 65 or older, immunocompromised and chronically ill patients,
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and in infants. Signs and symptoms include tachycardia, disorientation/confusion, discomfort,
fever or hypothermia, dyspnea, and perspiration.

1.2.

SEPSIS: A FORMAL DEFINITION

Sepsis has been in the medical consciousness for millennia and has been formally defined
several times. Louis Pasteur’s germ theory of disease attributed infection to harmful microbes,
thus spurring the first science-derived, empirically driven pursuit of sepsis comprehension. The
first modern definition of sepsis, posited by Hugo Schottmüller in 1914, was than more modern
definitions:
Sepsis is present if a focus has developed from which pathogenic bacteria, constantly or
periodically, invade the blood stream in such a way that this causes subjective and objective
symptoms.
(Gyawali et al., 2019)
More specifically, its definition has evolved as the pathophysiology of the syndrome and
pathobiology of affected tissues have enjoyed greater understanding. Subsequent official
definitions followed Schottmüller’s, most notably Sepsis-1, Sepsis-2, and Sepsis-3.
1.2.1. Sepsis-1
In 1991 the first consensus definition of sepsis was established at an American College
of Chest Physicians-Society of Critical Care Medicine (ACCP-SCCM) conference helmed by Roger
Bone. Bone made an argument for the improved definition of sepsis, and the importance of
precision of language in defining it (Bone, 1991). According to the proposed definition, sepsis
was a spectrum of systemic responses to infection ranging from systemic inflammatory
response syndrome (SIRS), to severe sepsis (sepsis complicated by organ dysfunction), to septic
shock (“sepsis-induced hypotension persisting despite adequate fluid resuscitation”) (Bone et
3

al., 1992). SIRS was the first of these stages of sepsis and so a definition considering the host’s
inflammatory response to infection as its foundational attribute followed. Sepsis-1 was ideally
framed to treat sepsis and SIRS as non-disjoint systemic responses to environmental factors
including but not limited to infection (Bone et al., 1992).

Table 1. SIRS Criteria

(Carneiro, Povoa, & Gomes, 2017)

Figure 1. SIRS, Sepsis, and Infection Venn Diagram
(Bone et al., 1992)
Four SIRS criteria were established: tachycardia (resting heart rate of over 90 beats per
minute), tachypnea (respiration rate of over 20 times per minute), body core temperature
dysregulation (fever: core temperature above 38°C; hypothermia: core temperature below
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36°C), and leukocytosis, leukopenia, or bandemia (leukocytes in greater concentrations than
1200/mm3, leukocytes in lower concentrations than 4000/mm3, or bandemia of ≥10%m,
respectively). The 1991 convention asserts that to be clinically diagnosed as SIRS-positive,
patients must exhibit two or more of these criteria (Marik and Taeb, 2017).
But the SIRS criteria proved to be far too general. If any two of the four SIRS criteria
were observed in patients, SIRS criteria were theoretically met, and thus the first “stage” of
sepsis would have been recorded as observed in such patients. For example, on average, up to
90% of intensive care unit (ICU) patients exhibit symptoms meeting SIRS criteria, to the extent
that they are eligible for sepsis diagnosis according to the Sepsis-1-SIRS criteria (Sprung et al.,
2006). Given that most infections induce some form of SIRS criteria (for example, tachycardia,
fever, high leukocyte counts) yet such infections less often result in actual recorded incidence
of sepsis (in the most relevant definition’s sense of the word), Sepsis-1 and its heavy reliance on
SIRS criteria represents a mischaracterization of infection and inflammation as sepsis. A new
definition was need.
1.2.2. Sepsis-2
In 2001, a task force met to address the limitations of the Sepsis-1 definition, and in so
doing attempted a reformed definition of sepsis, later coined “Sepsis-2” by the Journal of the
American Medical Association in 2016. The task force at the 2001 consensus conference sought
a more precise definition of sepsis via a thorough consideration of all clinical factors associated
with it. But what was intended as a conference to reform the definition of sepsis as a condition
commensurate with a few comorbidities resulted in loss of specificity and clarity as to what
constituted the condition. The Sepsis-2 baseline criterium was infection, included the four SIRS
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criteria from Sepsis-1, and several coinciding SIRS-related symptoms. These other symptoms
were grouped by “general parameters”, “inflammatory parameters”, “hemodynamic
parameters”, “tissue perfusion parameters”, and “organ dysfunction parameters”, and are
summarized in the following table:

Table 2. Sepsis-2 Criteria

(Carneiro, Povoa, & Gomes, 2017)
Though intended as a comprehensive reference for indicators of sepsis, many of the
criteria from this list were consistent with normal immune responses to infection. Despite its
intention for specificity, it broadened the scope of symptoms and subsequently was in danger
of identifying infection paired with any of the listed comorbidities as proxies for sepsis. To that
end, the conference was considered a failure, and Sepsis-1 persisted as the most relevant
definition for sepsis (Vincent, et al., 2013). Between 2001 and 2016 (Sepsis-3), advances in
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understanding of sepsis pathophysiology, etiology, pathobiology, and immunology were made,
which merited a new definition for the condition.

1.2.3. Sepsis-3
In 2016 the Journal of the American Medical Association (JAMA) proposed a third definition
of Sepsis that abandoned an argued overreliance on SIRS/inflammation, and instead opted to
treat the syndrome not as a continuum, but as a “life-threatening organ dysfunction caused by
a dysregulated host response to infection” (Singer et al., 2016). More specifically this definition
attempts to discriminate between past notions of sepsis and non-sepsis-related infection, to
account for pro- and anti-inflammatory responses associated with sepsis (which otherwise
would have been confounding, given previous definition’s reliance on inflammation/SIRS
criteria), and to establish the “primacy of the nonhomeostatic host response to infection, the
potential lethality that is considerably in excess of a straightforward infection, and the need for
urgent recognition” (Singer et al., 2016). This definition is argued to be the most and accurate
and practical addendum to AMA-sanctioned formal sepsis definitions because it accounts for
modern conventional wisdom while yielding that less understood influences (e.g. genetic or
cellular influences) could yet impact sepsis pathophysiology and pathobiology. In addition, the
definition was designed to address severe variations in sepsis incidence and mortality
attributed to a lack of standardized definitions for sepsis and septic shock. (Singer et al., 2016)
By restructuring and reforming the existing sepsis framework to instead focus on infection,
host response, and organ dysfunction, JAMA cited an improved understanding of pathobiology

7

(“organ function, morphology, cell biology, biochemistry, immunology and circulation”) as the
chief impetus for its revision (Singer et al., 2016).
Because this definition rejected the limited emphasis on inflammation placed by the Sepsis1 and Sepsis-2 definitions, new criteria constituting sepsis and septic shock were required.
Given that sepsis phenotypes differ across patient populations manifesting a range of
different comorbidities, interventions, and infections, a broader understanding of sepsis was
pursued. In response to this need, the 2016 task force suggested largely abandoning SIRS
criteria in favor of the Sepsis-related Organ Failure Assessment (SrOFA), renamed the
Sequential Organ Failure Assessment (SOFA) as primary criteria for diagnosis. SOFA criteria
were designed to identify signs of all previously identified sepsis symptoms, namely “infection,
host response, and organ dysfunction”. Under these guidelines, if a patient presents with a
SOFA score greater than 2, they are immediately assigned a 10% mortality risk to emphasize the
need for expedient treatment (even if symptom acuity has yet to manifest/rise). (Singer et al.,
2016)
A bedside SOFA inventory for patients already presenting with more acute symptoms
consistent with sepsis was also created. This quick SOFA survey, or qSOFA, has three criteria:
altered mental status, systolic blood pressure ≥ 100 mmHg, and respiratory rate ≥ 22 per
minute. Using qSOFA, patients meeting any two of these three criteria yielded a predictive
validity of 55% in accurately identifying sepsis. For this reason, qSOFA is suggested by Singer
and colleagues as an adequate tool for establishing whether subsequent investigation of
patient symptoms perhaps consistent with sepsis is necessary. Moreover, qSOFA requires no
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lab analyses, making it an expedient, cheap, abridged alternative to an initial, more invasive,
and expensive SOFA assessment. (Singer et al., 2016)
Despite the shift to SOFA/qSOFA, a noncontroversial consensus definition for sepsis remains
unfulfilled. The 2016 conference conceded that a consolidated, simple definition of sepsis was a
lofty goal, given the understanding of etiologic-specific pathophysiology and pathobiology of
individual sepsis incidences. The task force charged with pursuing this goal instead offered a
prognostic tool for subsequent testing if either a. a patient presented with infection and was
already suspected sepsis-positive, or b., a patient exhibited any two of the three qSOFA criteria
indicating significant likelihood of mortality absent a health intervention.

1.3 A Critique of the 2016 Sepsis Definition
Though the authors’ intentions behind establishing tools for outcome prediction associated
with sepsis were good, and though the SOFA/qSOFA scoring systems proved useful tools in a
prognostic sense, the authors failed to propose a new and valid sepsis diagnostic tool and
definition. In the authors’ own words:
The agreement between potential clinical criteria (construct validity) and the ability of the
criteria to predict outcomes typical of sepsis, such as need for intensive care unit (ICU)
admission or death (predictive validity, a form of criterion validity), were then tested.
(Singer et al., 2017)
This statement suggests that the aim of the qSOFA/SOFA tools was for outcome prediction on
encountering symptoms consistent with sepsis. The proposed diagnostic framework was less of
a valid proposal for establishing a systematic diagnostic decision algorithm, and more a critique
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of a past overreliance on inflammation as a valid metric for sepsis. Semantics were modified to
eliminate “severe sepsis” as clinically distinguishable from “sepsis”.
The reason that this is a substantive argument against the current Sepsis-3 framework
(and for an alternative model) is because clinicians in the intensive care unit (ICU) are tasked
with maximizing healthcare outcomes of unstable, acutely sick patients population. This, in
contrast with emergency department (ED) clinicians’ responsibilities for health diagnoses and
treatment, represents a discrepancy in the intended changes proposed by the Sepsis-3
framework from its predecessors. Moreover, qSOFA and SOFA are recorded as having been
validated in an ICU-environment; but sepsis is not limited to the ICU. Prognosis cannot be
equated with diagnosis. Effect does not equal cause.
Because medically applied machine learning models and clinical decision support tools
are becoming increasingly ubiquitous in the clinical space and given the heavy burden that
sepsis represents to the American healthcare system, integration of relevant machine learning
models with existing and legacy sepsis diagnostic models deserves serious and immediate
attention. Rather than using solely Sepsis-3, clinician gestalt, and electronic health record (EHR)
maintained patient health history, the current sepsis diagnostic framework deserves an update.
Machine learning can be leveraged to augment the current model of sepsis via comorbidity
identification, and ideally, to offer organ-system-specific/context-specific sepsis ‘strain’
diagnosis.
Where symptom-non-disjointness can make sepsis diagnosis convoluted and intangible,
machine learning can rectify this issue. Machine learning can augment conventional wisdom via
robust calculation of probabilities of disease given the presence or absence of specific features.
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Such features are limitless: age, sex, weight, blood pressure, health history, family health
history, active comorbidities, living situations, active medications, etcetera. Machine learning
thus represents a modern tool capable of delivering the intended outcomes of evidence-based
medicine.
This argument is admittedly neither radical nor new. However, the reform of a
consensus definition with one that integrates machine learning into its methodology is less
common. Existing predictive analyses for sepsis are predicated on conventional wisdom
established by criteria outlined in any one of the three modern definitions for sepsis. To the
author’s knowledge, all machine-learning applications of sepsis prediction suffer from nongeneralizable outcomes given limited scope in data sourcing. Populations are often limited to a
specific, sometimes predisposed subset of patients whose incidences of disease represent a
frequency greater than that of the general public. One study by Calvert and colleagues sought
to establish a generalizable machine learning diagnostic tool for sepsis, conceding the same in
their methodology (Calvert, Saber, Hoffman, & Das, 2019). An improved understanding that
there exist heterogenous manifestations of sepsis has meant that the simple, clear-cut
definition as conceived by past consensus conferences may not be attainable. Consequently,
machine learning-based approaches are the next logical step in the process.
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2. METHODS
The data used for this study were procured from an online repository of clinical trial
data and required preprocessing and feature selection prior to predictive modeling.

2.1 DATA SOURCE
The investigation and efficacy of new medical interventions is logged and evaluated by
execution of randomized clinical trials, the results of which are added to a repository of clinical
trial data in clinicaltrials.gov on completion. Because clinical trials represent new and
exploratory analyses on the viability of specific medical interventions there exists an element of
risk in their execution. Such risk often manifests in the form of adverse events.
To assess the frequency of target adverse events across multiple clinical trials and to
leverage machine learning capability to the data, reformatting into a standardized, numerically
indexed scale was required. The LibSVM format is a vectorized representation of data assigning
discrete index keys to unique features, and integer, float, or Boolean values representing those
features. It is this standardization that potentiates subsequent cross-trial study, given the
machine-readable format that it creates. Thanks to this format standardization executed by
Tong and colleagues, 30,915 clinical trials were compared with 128,799 unique features
between them (Tong et al., 2019). Said features belonged to six separate categories: participant
information (discrete values), trial phase (discrete values), serious adverse event
(binary/Boolean), other adverse event (binary/Boolean), preexisting condition
(binary/Boolean), and interventions (binary/Boolean).
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2.2 DATA TRANSFORMATION AND PREPROCESSING
Prior to employment of any machine learning methods, the vectorized data required
significant cleaning and preprocessing. Though standardized across multiple clinical trials, the
data required further attention for several reasons.
First, all features involving sepsis required removal from the feature space of the data to
properly generate target labels denoted by the presence (1) or absence (0) of sepsis outcomes
from that clinical trial. A corresponding dataset of feature headers was used to produce a list of
sepsis feature headers whose index numbers were referenced and removed while parsing the
data.
Second, extraneous features required removal; said features included the clinical trial
ID, number of participants, participant median age, total serious adverse events (n=30915), and
total, other adverse events (n=30915). The former three features were continuous; the aim of
the study was to consider binary/Boolean “presence” or “absence” of features as predictors.
The latter two features existed in every clinical trial; the information gained from their inclusion
was zero, due to zero variance within each respective feature. None of these features would be
useful since the aim of this study was to determine predictive power of factors for sepsis events
in a clinical trial context.
Third, prior to model-fitting, the dataset was a textbook case of the so-called “curse of
dimensionality” due to its large feature space volume and large ratio of features to rows. Such
quantity of features almost certainly makes for model overfitting, rendering outcomes devoid
of any clinical significance or meaning. A few methods were investigated and used to lower
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chances of over- and under-fitting, namely methods belonging to the families of feature
selection, and feature dimensionality reduction alongside regularization.
Below are the raw data as they were received following normalization into this sparse
vector format:

Figure 2. Raw Sparse Data
A separate table mapping each clinical trial feature to a key/index was referenced to search the
raw data for features related to sepsis, but excluding “aseptic”:

Figure 3. Feature Headers
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The following figure is the Python code used to reformat the raw data by excluding sepsis
events from the feature space and adding a binary class field indicating presence or absence of
sepsis:

15
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Figure 4. Preparing the Data

Figure 5. Pre-Feature-Selected Data
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2.3. FEATURE SELECTION
Feature selection was important in the case of this study because of the high
dimensionality of the feature space (n=128,799) with respect to the number of clinical trials
(n=30,915). To that end, filter feature selection methods were used. Wrapper methods were
considered, but high feature dimensionality can often render wrapper methods subject to
overfitting (Ciortan, 2019). In addition, filter methods were selected as an attempt at premodelling data standardization; performance could be based solely on the model, and not on
any embedded feature selection parameters within each model. Feature selection helps
mitigate issues of overfitting and underfitting the data. Absent feature selection, models may
learn the variability in the data too well and consequently overoptimize parameters to fit with
the training data only, thus overfitting the model. Conversely, models may be vulnerable to
underfitting the data (as is the case with features with low variance). This give-and-take
between balancing underfitting (low variance, high bias) and overfitting (high variance, low
bias) is the root conflict of the bias-variance-tradeoff.
It should be added that prior to feature selection data are often normalized when the
numeric scales between each of the feature columns differ. Data normalization is useful when
dealing with continuous features, each with their own distinct numeric ranges. Because all
features in the selected feature space were binary (either 0, indicative of “absent”, or 1,
indicative of “present”), no such normalization was necessary (Jaitley, 2019).
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2.3.1 Variance-Based Feature Selection:
The removal of features with low variance is a necessary step in cleaning the data for
successful modeling results. Intuitively, if there exists low variance in features, there exists high
similarity among the instances of said features. If a single feature has the same value across
many clinical trial instances, the model will learn from these features, to the extent that it
underfits the model. The scikit-learn feature_selection module and its
VarianceThreshold method were used to remove all features with zero variance. This

method uses a default of 0; thus all features that appeared the same across all 30915 clinical
trials were removed. Subsequent retroactive selection of variance thresholds was performed
following model execution, and a minimum threshold of variance = 0.01, or 1% (preserving 99%
of all variance of the dataset), was ultimately selected. This narrowed the feature space from
128,799 to 754.

2.3.2 Correlation-Based Feature Selection:
Correlation-based feature selection operates on the assumption that “a good feature
subset is one that contains features highly correlated with (predictive of) the class, yet
uncorrelated with (not predictive of) each other” (Hall, 1999). The challenge with a dataset
containing semantically different but conceptually similar features (for example, “lesion”,
“cancer”, “tumor”, “malignant lesion”, etcetera) is to not limit the number of features
represented in the final model at the expense of feature uniqueness. For this reason,
correlation-based feature selection was used to further select features in the top 20% of fstatistics derived from the ANOVA F-test, implemented by the scikit-learn f_classif method
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from the ‘feature_selection’ module. This method returns features’ respective F-Statistics and
p-values, or the probability that the null hypothesis is true. In other words, p-values are used to
determine if mean feature values across positive and negative classes are equal, or, that a
feature’s presence is independent of the target class. On running the f_classif method on
the 754 variance-selected features, 306 had p-values of zero. It should be mentioned, however,
that all but 13 features had p-values greater than 1%; thus exclusive reliance on p-values for
feature importance measurement would have been fallacious. On identifying an f statistic
threshold of 20% the correlation-based method selected the final 151 features to be used in
model training. These final 151 features were most correlated with sepsis, in that they had the
highest ANOVA F-test statistics among the features. Below are the top 10 features as ranked by
their f-statistics:
Table 3. Features and F-Statistics
Name

F-Statistic

Phase 2/3

11828.65

Pyrexia

9821.41

Pneumonia

9665.61

Myocardial Infarction

8926.04

Cellulitis

8876.59

Atrial Fibrillation

8605.05

Chest Pain

8215.73

Dehydration

7857.79

Back Pain

7687.53

Anemia

7634.04
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2.4 DIMENSIONALITY REDUCTION
It should be mentioned that feature selection and dimensionality reduction, though
both filtering down the number of features, are two distinct operations. Whereas feature
selection excludes selected features from models without changing those features,
dimensionality reduction transforms features into a lower dimensional space, by which feature
selection automatically follows.

2.4.1 Truncated SVD:
Truncated Singular Value Decomposition (SVD) were initially pursued as an attempt at
dimensionality reduction. However, given that the objective of this study was to examine and
evaluate discrete clinical trial features as individual predictors of sepsis, and given that
truncated SVD consolidates related feature vectors into a summed eigenvector, an implicit loss
in granularity of features would have occurred. Moreover, since truncated SVD outputs a
predetermined number of vectors, all of which represent generalized eigenvalues of clinical
categories, the clinical usefulness of such an output would be difficult to argue in the context of
this study. Clinicians are already aware of broad domain-specific covariates of sepsis. The aim
here, was to attempt to identify more specific outputs/features.
The output of truncated SVD is graphically represented in a generic, oversimplified form
for four model principal components. To note, superscripts indicate correlation with the base
feature (such that AE and EA communicate some degree of similarity between features A and E).
In this simplified diagram, red vectors represent the sum (a principal component) of two
vectors found to have high collinearity.
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Figure 6. Simplified linear algebra of the Truncated SVD algorithm

Truncated SVD operates on the principle that, in a vector space, a linear map (or a
matrix) is a combination of rotated, reflected, scaled, and killed (scaling by 0) vectors. This holds
so long as the axes defining that vector space are valid. SVD is a technique leveraging matrix
factorization by synthesizing three child matrices from a matrix. (Charan, 2020)
More specifically, if A is a matrix, or linear map, from an n-dimensional vector space V to
an m-dimensional vector space W, then A can be considered a product of 3 other matrices, R,
D, and S. Here S is an “n x n” rotational matrix with source and target both V; D is an “m x n”
diagonal matrix with source V and target W: only non-zero entries are on the diagonal; R is an
“m x m” rotational matrix with source W and target W.
First vectors in space V are rotated using S. Second those same vectors are scaled by
some constant, and inputted into W by using axes from the map, A. Finally, those output
vectors are rotated in W using the R rotational matrix. (Charan, 2020)
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𝑎11
A=[ ⋮
𝑎𝑚1

⋯ 𝑎1𝑛
⋱
⋮ ]
⋯ 𝑎𝑚𝑛

Vdim=n

Wdim=m
A = R*D*S

𝐴 = 𝑆: [

𝑠1
𝑠3

𝑑1
𝑠2
] ∗ 𝐷: [𝑑3
𝑠4
𝑑5

𝑟1 𝑟2 𝑟3
𝑑2
𝑑4] ∗ 𝑅: [𝑟4 𝑟5 𝑟6]
𝑟7 𝑟8 𝑟9
𝑑6

Figure 7. Simplified Truncated SVD Component Vector Addition
(Charan, 2020)
The SVD technique is similar to another dimensionality reduction technique called
Principal Component Analysis (PCA); however, the former operates on raw data matrices, while
the latter operates on a covariance matrix (Avila & Hauck, 2017). The incompatibility of PCA
with sparse data stems from the fact that it requires operation on an entire matrix (via
calculation of a covariance matrix), whereas SVD does not.
Truncated SVD could be useful in subsequent studies to determine organ-systemspecific predictors for different pathobiologies of sepsis. However, for the purposes of this
study, it is reiterated that truncated SD was abandoned in favor of feature granularity.
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2.5 CROSS VALIDATION
Cross validation is typically most useful for datasets with limited numbers of
observations (Avila & Hauck, 2017). One type of cross validation called k-fold cross validation
splits training data into a selected number of equally distributed parts, or folds, assigning one of
the folds as a holdout, or test set; the remaining k – 1 folds are used to train the model. For
example, a k-fold cross-validation where k = 100 is a 100-fold cross validation. The model will be
iteratively trained using each of the 99 training folds and will test the accuracy of the model by
feeding it the hold-out set. Outputted from a 100-fold cross validation model evaluation are
100 k scores, which are averaged, and represent the mean model performance. (Kelleher,
Namee, & D’Arcy, 2015)

Figure 8. K-fold Cross-Validation
(Kong, 2017)
Given the size of the dataset and given the low computational cost of using the built-in
train_test_split method of the model_selection module, cross validation was
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considered but not pursued. This module randomly partitions arrays and/or matrices into
training and testing folds of the original dataset. In the case of both the logistic regression
baseline model (nfeatures = 128,799) and the feature-selected logistic regression model
(nfeatures=151), 10-fold cross validation was performed on the dataset. In comparing crossvalidated performance with train_test_split performance, no statistically significant
advantage in the form of better performance was observed in using the former over the latter.

2.6 MODELS
There is a phrase in data science and machine learning that there is “no free lunch when
it comes to model selection”; there is no single model that unilaterally performs better across
all instances (said instances being data inputs and desired outputs) (Fermin, 2019). Because of
this, a number of models were chosen to determine the predictive power of the cleaned clinical
trial data. These included logistic regression, support vector machines (SVM) with using linear,
polynomial, sigmoidal, and radial basis function (RBF) kernels, naïve Bayes classifier, decision
trees, and ensembles of decision trees called random forests. classes.
Following model prediction on subsets of testing data, cross-model performance was
evaluated to ultimately select the best-performing model. It should also be added that each of
these models belonged to the family of supervised machine-learning classifiers: supervised
because the features and classes were labeled; classifiers because the object is to determine
predictive power of datasets with feature labels, and subsequently evaluate and classify the
predictive power of each feature.

25

2.6.1 Logistic Regression
Logistic regression (LR) is a binary classification algorithm that assigns a class to a
categorical feature via application of a 50% probability (Geron, 2019). LR calculates the
weighted sum of the entire input feature space and outputs its biased logistic, scaled between 0
and 1, where an output greater than 0.50 indicates positive association with the target variable,
and an outcome less than 0.50 indicates a negative association with the target variable. More
specifically, LR applies the sigmoid function [0,1]:
1

σ(x) = (1+𝑒 −𝑋 )
or graphically represented:

Figure 9. Sigmoid Function
(sklearn.linear_model.LogisticRegression, 2020)
Within this scale [0.0, 1.0], all logistic regression models estimate probabilities that some
feature/instance belongs to a class, or that:
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𝑝̂ = ℎ𝜃 (x)
Where 𝑝̂ equals the calculated probability that the instance, x, belongs to the category, ℎ𝜃 . In
the context of this case study:
𝑦̂ = {

0 𝑖𝑓 𝑝̂ < 0.5
that a feature is consistent with sepsis
1 𝑖𝑓 𝑝̂ ≥ 0.5

where 𝑦̂ is the classification produced by the model. Thus it stands to reason that if an
estimated probability that a feature belongs to the sepsis class equals 0.6, there is a 60%
chance that a feature will predict sepsis.
Though logistic regression produces such probabilities according to this non-linear
1

sigmoidal function, it is still considered a linear model because on solving σ(x) = (1+𝑒 −𝑥 ) for x,
where the sigmoid, σ(x), equals p (or the probability that an observation belongs to the
response variable/class):
1

𝑝 = (1+𝑒 −𝑋 ) (𝑠𝑖𝑔𝑚𝑜𝑖𝑑 𝑓𝑢𝑛𝑐𝑡𝑖𝑜𝑛)
𝑒 −𝑋 =
𝑒 −𝑋 =

1
𝑝

1
−1
𝑝

𝑒 −𝑋 =
𝑝

1−𝑝
𝑝
𝑝

𝑒 𝑋 = 1−𝑝 ↔ 𝑞
𝑋 = log

𝑝
𝑞

(𝑙𝑜𝑔𝑖𝑡 𝑓𝑢𝑛𝑐𝑡𝑖𝑜𝑛)
(Klosterman, 2019)
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the resulting equation for the log odds, or odds ratio, represents a probability given a linear
combination of all features in the feature space. Thus, because X, or the aggregate linear
combination of features when the response variable equals the logit function, logistic
regression is a linear model. In other words, given a feature space of size n:
1

𝑝 = (1+𝑒 −(𝜃0+𝜃1𝑋1 +𝜃2𝑋2 +⋯𝜃𝑛𝑋𝑛 ) ) (sigmoidal logistic regression)
𝜃0 + 𝜃1 𝑋1 + 𝜃2 𝑋2 + ⋯ 𝜃𝑛 𝑋𝑛 = log

𝑝
𝑞

(log odds logistic regression)

Because the sigmoid equation can be unilaterally generalized with such a transformation into
the logit function, or, into a 𝑦 = 𝑚𝑥 + 𝑏 form, it is proven that logistic regression is linear.
(Klosterman, 2019)
2.6.1.1 REGULARIZATION
Lasso and Ridge regularization methods are two methods that assign penalty, or cost,
for having larger coefficients in a fitted model. In short, these methods assign cost, or penalties
for predicting values incorrectly, and in doing so are integral in parameter optimization for
returning the least “costly” model. By doing this, the model learns from an inputted training set
of data for model fitting that can generalize to new data on being asked to predict outcomes.
The log-loss function is one such cost function used in scikit-learn for penalty assignment and
model fitting in a number of models, but most notably logistic regression:
𝑛

1
log 𝑙𝑜𝑠𝑠 = 𝐻𝑝 (𝑞) = ∑(𝑦𝑖 ∙ log(𝑝𝑖 )) + (1 − 𝑦𝑖 ) ∙ log (1 − 𝑝(𝑦𝑖 ))
𝑛
𝑖=1

(Klosterman, 2019)
where n is equal to the number of samples, 𝑦𝑖 is equal to the actual label of a sample of index, I,
and 𝑝𝑖 is the probability that a sample at index I belongs to the target class (or 𝑝(𝑦𝑖 ) = 1). By
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optimizing model parameters, the response variable log odds and individual features’ log odds
are calibrated to the other to minimize the cost function. Log loss is also called the crossentropy function, or simply the “difference between two probability distributions for a given
random variable or set of events” (Brownlee, 2019).
Two extrapolations on the log loss function are lasso (L1) and ridge (L2) regularization
methods. Both methods leverage the log loss function, but each use a different term to
minimize the cost function. The L1 regularization appends the log loss with the 1-norm:
𝑚

𝑛

𝑗=1

𝑖=1

𝐶
lasso penalty log loss = ∑|𝜎𝑗 | + ∑(𝑦𝑖 ∙ log(𝑝𝑖 )) + (1 − 𝑦𝑖 ) ∙ log(1 − 𝑝(𝑦𝑖 ))
𝑛

and the L2 regularization appends the log loss with the 2-norm.
𝑚

ridge penalty log loss =

∑ 𝜎𝑗2
𝑗=1

𝑛

𝐶
+ ∑(𝑦𝑖 ∙ log(𝑝𝑖 )) + (1 − 𝑦𝑖 ) ∙ log(1 − 𝑝(𝑦𝑖 ))
𝑛
𝑖=1

(Klosterman, 2019)
Except for the operations performed by the first term, the two regularization models are
identical. The key difference is that L1 includes the sum of absolute values of coefficients
between m different features, whereas L2 includes the sum of squares. With respect to
performance, L1 can be used as a feature selection method if given a coefficient equal to
exactly zero, as this assignment eliminates the feature. L2 penalties do not eliminate features
given a coefficient value of zero.
In the case of this study, binary logistic regression was used, given that the response
variable accounted for two possible outcomes: sepsis, and not sepsis. Within the
LogisticRegression method, cost penalties L1 or L2 are specified.
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2.6.1.2. Solvers
The LogisticRegression method also accepts a solver parameter. Solvers find
parameter weights for further minimizing the cost function, previously specified. Used in this
study were liblinear, sag, and saga solvers.
The liblinear solver minimizes the cost function from a single direction at a time; given
this detail, logistic regression with this solver performed noticeably slower than the same
models using gradient descent. Sag, or the stochastic average gradient descent solver,
abbreviates parameter calculation by randomly sampling in-cache gradient values, but is limited
to L2 regularization. Saga is a variant of Sag, but instead is compatible with L1 regularization,
which allows for input of sparse data. Both the sag and saga solvers are optimized for larger
datasets. (sklearn.linear_model.LogisticRegression, 2020)

2.6.2 Support Vector Machine (SVM)
Support vector machines (SVM) are another form of classification algorithm but do not
require linearity for classification. SVMs determine and optimize two-, three-, or multidimensional hyperplanes as modes of classification, as well as decision boundaries in cases
where data points are not unilaterally/linearly separable. Ultimately SVM aims to separate
datapoints by some maximum distance from a hyperplane called a margin (Kelleher, Namee, &
D’Arcy, 2015). The support vectors are those datapoints.
In cases where separability is indeed not linear, additional functions called kernels are
applied for decision function specification. Kernels ultimately act as operators that apply some
weight to the data, transforming the distances between datapoints in the aggregate so a
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hyperplane is more easily found. Weights may be unilaterally applied (linear) or nonlinear,
depending on the kernel function. This is simplified for the sake of exposition below, where a
two-dimensional feature space (where data are non-linearly separable via hyperplane) is
kernelized, or projected, into a three-dimensional feature space (where data are linearly
separable via a hyperplane with maximum margin):

(Fletcher, 2009)
Figure 10. Kernel Trick for Hyperplane Identification
Kernels provided by sklearn include a linear, polynomial, radial basis function (RBF), or
sigmoid (similar to logistic regression). Below is the famous Iris dataset, operated on by multiple
SVMs-based kernels:
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Figure 11. Various SVM Kernel Applications on Iris Dataset
(sklearn.svm.LinearSVC, 2020)
2.6.2.1 Linear Kernel
The linear kernel in a support vector machine is used when data is linearly separable.
This kernel is most typically used when the data have many features and two classes, making
this kernel ideal for the dimensions of the dataset. A linear hyperplane can be a line in two
dimensions, or a plane in three dimensions, and can be represented in a standard 𝑦 = 𝑚𝑥 + 𝑏
format, with dimensions as parameters:
𝛽 0 + 𝛽1 𝑋1 + ⋯ + 𝛽𝑛 𝑋𝑛 = 0
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2.6.2.2. Radial Basis Function Kernel
The Radial Basis Function (RBF) kernel is a kernel used under similar circumstances to
the linear kernel, but instead takes Euclidean distance between data points into account. The
RBF Gaussian kernel is as follows:
𝑘𝐺 (𝑥, 𝑥 ′ ) = exp (−

𝑑(𝑥, 𝑥 ′ )2
)
2𝜎 2

where σ equals a parameter, and d is the Euclidean Distance (or direct-line distance) between
the two data points x and x’ (Vert, Tsuda, & Schö lkopf, 2004).

2.6.3 Naïve Bayes
Naïve Bayes classification is another classification algorithm that naively assumes
feature independence in class prediction. Below, the simplified Bayes’ Theorem:
𝑃(𝐴|𝐵) =

(𝑃(𝐵|𝐴) ∗ 𝑃(𝐴))
(𝑃|𝐵)

As an example applied to the context of this study, if sepsis is related to blood pressure, then,
using Bayes’ theorem, a person's blood pressure can be used to more accurately assess the
probability that they have sepsis than can be done without knowledge of the person’s blood
pressure.
A Naïve Bayes assumption states that features are conditionally independent of each
other given some response variable. Or:
𝑃(𝑋1|𝑋2, 𝑌) = 𝑃(𝑋1|𝑌)
or in the case of the 151 features from the dataset:
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P(Sepsis|X1,X2,…,X151)
and applied to Bayes’ Theorem:
𝑃(𝑠𝑒𝑝𝑠𝑖𝑠|𝑋1 , … , 𝑋151) =

𝑃(𝑋1|𝑠𝑒𝑝𝑠𝑖𝑠)𝑃(𝑋2|𝑠𝑒𝑝𝑠𝑖𝑠) … 𝑃(𝑋151|𝑠𝑒𝑝𝑠𝑖𝑠)𝑃(𝑠𝑒𝑝𝑠𝑖𝑠)
𝑃(𝑋1 )𝑃(𝑋2 ) … 𝑃(𝑋151 )

The denominator remains unchanged and can thus be eliminated when determining class
outcome:
𝑃(𝑠𝑒𝑝𝑠𝑖𝑠|𝑋1 , … , 𝑋151) ∝ 𝑃(𝑋1|𝑠𝑒𝑝𝑠𝑖𝑠)𝑃(𝑋2|𝑠𝑒𝑝𝑠𝑖𝑠) … 𝑃(𝑋151 |𝑠𝑒𝑝𝑠𝑖𝑠)𝑃(𝑠𝑒𝑝𝑠𝑖𝑠)
Then, given predictors, Sepsis can be identified:
151

𝑠𝑒𝑝𝑠𝑖𝑠 = 𝑎𝑟𝑔𝑚𝑎𝑥𝑠𝑒𝑝𝑠𝑖𝑠 𝑃(𝑠𝑒𝑝𝑠𝑖𝑠) ∏

𝑖=1

𝑃( 𝑋𝑖 |𝑠𝑒𝑝𝑠𝑖𝑠)

Naïve Bayes classifiers uses maximum likelihood estimation for parameter estimation, taking
into account conditional probability and prior probability. There exist multiple types of Naïve
Bayes classifier. The two used in this study included Bernoulli and Gaussian Naïve Bayes. The
former uses Boolean features for class prediction (0 and 1), and the latter uses continuous
features.

2.6.4 Decision Tree
Decision trees are recursive decision structures that seek to maximize quantifiable
information gain by identifying the most informative feature for each node and applying
subsequent decision splits to each subsequent feature. These algorithms are instantiated at an
aggregate “bin” of all possible features, called a root node, representative of the population
being sorted. Each subsequent decision point below the root node is called a node, and final
decisions where no further splits are necessary are called terminal nodes.
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(Datacamp, 2019)

Figure 12. Decision tree: unpruned
Decision trees are among the most popular machine learning algorithms because they
are almost immediately interpretable both in rationale and practice; the issue of the machine
learning “black-box” is less likely to apply to decision trees. Additionally, they are capable of
both regression and classification tasks (predicated on whether the machine learning problem
is concerned with continuous or categorical features), making them versatile and good baseline
models against which to compare other non-tree-based models or ensemble tree models.
Decision splits are determined by a number of different decision rules, but in the case of
this study were Entropy and Gini rules. The former determines the variety of possibilities, or
disorder, of a target variable. The latter is a measure of the impurity, or the rate at which a
randomly chosen feature predicts the wrong class.
A few popular decision trees algorithms include the Iterative Dichotomizer 3 (ID3), CART
(Classification and Regression Trees), CHAID (Chi-squared Automatic Interaction Detection for
classification tasks). A number of derivative machine learning algorithms have come from
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decision tree classifiers including fast and frugal trees (minimally deep/maximally shallow
decision trees designed to aid decision flows in professional spaces where the bulk of decisionmaking can be distilled down to a few crucial steps), and extrapolative bootstrapping models
like random forests and gradient boosted decision trees.
Decision trees are at a disadvantage when used on their own or when working with data
of high dimensionality. If not for the feature selection and engineering methods employed, the
high variance of the data would have caused a non-generalizable model. Despite this, a decision
tree model was applied to the dataset for the sake of exposition re: the continuum of treebased classifiers ranging from decision trees to random forest classifiers (and perhaps in
subsequent study, gradient boosted tree algorithms) and its clear representation of knowledge.

2.6.5. Random Forests
Random forests bagging ensembles, or collections/forests of decision trees that have
been bootstrapped. Bootstrapping is the process of resampling the training dataset in parallel
with model fitting and replacing poorly performing samples. Bootstrapping aggregates all these
inputs via a number of different techniques, but sklearn compiles a list of all predicted
probabilities for each feature, selecting the feature with the highest probability as an output.
On generating some specified number of decision trees with the n_estimators parameter,
trees are averaged, and a prediction is outputted (sklearn, 2020).
Random forests are greater than the sum of their parts, in that their strength lies in the
numbers of their constituents. Outputs are committee-based and represent a collective
“agreement” among the group.
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3. OBJECTIVES

The objectives of the study were three-fold. First, the study was a practice in data
manipulation and reformatting, which required in-depth understanding of data structures and
data types. Before the data were ready for machine learning, there existed multiple indexed
sepsis events that required removal from the feature space, but whose presence or absence
required denoting.
Second, this thesis represented an introduction to medically applied machine learning as
well as feature and model selection.
Third, this thesis aimed to contribute to two conversations. The first, that the
continued/further integration of machine learning applications into the clinical space could
supplement modern evidence-based medicine best-practices for disease diagnosis, prediction,
and prevention/intervention, thus potentiating maximal health outcomes. The second, that a
new sepsis definition should be pursued, ought to incorporate machine learning into its
underlying framework, and should require explicit diagnostic criteria including covariates of
disease, rather than settling on ED/ICU-gathered prognosis outcomes self-described as markers
for diagnosis. It is reiterated that use of prognostics as diagnostics for sepsis is dangerous,
especially when the most dire prognoses are accepted as criteria for sepsis to begin with.
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4. RESULTS
Table 4. Optimized Model Results Table
Algorithm
Logit
SVM
Naïve Bayes
Decision Tree
Random
Forest

Tags
No Sepsis
Sepsis
No Sepsis
Sepsis
No Sepsis
Sepsis
No Sepsis
Sepsis
No Sepsis
Sepsis

Feature Selected Model
Precision Recall F1-Score AUROC
0.94
0.97
0.95
0.79
0.77
0.61
0.68
0.94
0.97
0.95
0.78
0.78
0.58
0.67
0.95
0.91
0.93
0.83
0.56
0.71
0.62
0.92
0.97
0.94
0.73
0.71
0.51
0.59
0.93
0.97
0.95
0.78
0.76
0.72
0.74

Accuracy
0.92
0.92
0.86
0.91
0.92

TP = True Positive
TN = True Negatives
FP = False Positive
FN = False Negative
𝑇𝑃

𝑇𝑃

𝑇𝑃

Recall = 𝑇𝑃+𝐹𝑁 𝑜𝑟

Precision =𝑇𝑃+𝐹𝑃 or 𝐼𝑑𝑒𝑛𝑡𝑖𝑓𝑖𝑒𝑑 𝑃𝑜𝑠𝑖𝑡𝑖𝑣𝑒𝑠

𝑇𝑃
𝐴𝑐𝑡𝑢𝑎𝑙 𝑃𝑜𝑠𝑖𝑡𝑖𝑣𝑒𝑠

𝑃𝑟𝑒𝑐𝑖𝑠𝑖𝑜𝑛∗𝑅𝑒𝑐𝑎𝑙𝑙

F1 = 2 ∗ 𝑃𝑟𝑒𝑐𝑖𝑠𝑖𝑜𝑛+𝑅𝑒𝑐𝑎𝑙𝑙
The results table includes precision, recall and f1 scores for each of the feature-selected
selected models. The random forest model performed best and identified phase 2/phase 3,
phase 3/phase 4, sleep apnea syndrome, deep vein thrombosis, dyspnea, atrial Fibrillation,
chronic obstructive pulmonary disease, cancer pain, acute cholecystitis, peritonsillar abscess as
the top ten most predictive features.
The best performing models are summarized with the following AURCOCs, and
normalized/non-normalized confusion matrices.
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4.1. Logistic Regression: Sag Solver

Figure 13. AUCROC For Logistic Regression Sag Solver

Figure 14. Logistic Regression Sag Solver Confusion Matrix

39

Figure 15. Normalized Confusion Matrix for Sag Solver

40

4.2. Support Vector Machines: Linear Kernel

Figure 16. AUCROC for SVM.SVC Linear Kernel

Figure 17. SVM.SVC Linear Kernel Confusion Matrix
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Figure 18. Normalized SVM.SVC Linear Kernel Confusion Matrix
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4.3. Naïve Bayes Classifier: Gaussian Classifier

Figure 19. AUCROC For Naïve Bayes Gaussian Classifier

Figure 20. Naïve Bayes Gaussian Classifier Confusion Matrix

43

Figure 21. Normalized Naïve Bayes Gaussian Classifier Confusion Matrix
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4.4 Decision Tree: Gini Depth 10

Figure 22. AURCOC for Gini Impurity Depth 10 Decision Tree

Figure 23. Gini Impurity Depth 10 Decision Tree Confusion Matrix
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Figure 24. Normalized Gini Impurity Depth 10 Decision Tree Confusion Matrix
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4.5. Random Forest: Gini Impurity

Figure 25. AUROC for Random Forest Gini Impurity

Figure 26. Random Forest Gini Impurity Confusion Matrix
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Figure 27. Normalized Random Forest Gini Impurity Confusion Matrix
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5. DISCUSSION
Given that only 4,367 of the 30,915 (14%) of clinical trials reported any incidences of
sepsis, the issue of class imbalance was significant. In machine learning, the most accurate
models are those trained on data with classes that are near equal in distribution. In the case of
binary response variables (0 for no sepsis, 1 for sepsis), this optimal distribution would have
had 15,458 incidences each of sepsis and no sepsis.
Accuracy scores were likely bloated due to class imbalance as well. Moreover, an overreliance on accuracy as a robust assessment of the models’ performances in the instance of this
dataset would be misleading. Because models predict both sepsis-related (1) and non-sepsisrelated (0) events, and because the ratio of non-sepsis:sepsis in the data is roughly 7:1,
accuracy figures are too heavily influenced by the models’ specificities (true negative rate). The
same weight is being given to specificity as sensitivity, despite the class imbalance.
A subsequent study could work to further improve preprocessing steps to target a 1:1
ratio class events using a technique called the Synthetic Minority Over-sampling Technique, or
SMOTE (Chawla, Bowyer, Hall, & Kegelmeyer, 2002). This method synthetically generates new
samples consistent with the minority class distribution and is available in the
imbalanced_learn library’s SMOTE class. Further investigation into boosted ensemble
classifiers like gradient boosted trees/models, Adaboost, or XGBoost could be a means of
applying the subject matter of this study to more relevant and modern models.
Finally, as the title suggests, the approach to sepsis classification is naïve, in that sepsis
events are lumped into a single feature. Given that that modern understanding of the
pathobiology and pathophysiology of sepsis suggests its mechanism may be organ-system
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specific, the follow-up study could assign nominal or ordinal categories to different sepsis
categories.
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6. CONCLUSION
The healthcare industry is experiencing a paradigm shift in how it identifies, describes,
predicts, intervenes, and prevents major adverse health outcomes thanks in large part to
machine learning models. Constant revision of modern machine learning techniques guarantees
improved results. When applied to healthcare, such improved results are assumedly countless.
It is difficult to conceive of a future where machine learning will not continue to impact
healthcare, if not already doing so. Machine learning is becoming increasingly common in the
healthcare data space including but not limited to: clinical decision support tools; health vitals
analytics and prediction made possible by data generation and aggregation from wearable
health devices, electronic health record data, and insurance health claims data; image
processing of medical images for early detection of disease; pharmaceutical development and
design via machine learning aided discovery of prognostic biomarkers (Vamathevan et al.,
2019); and this list continues to grow.
In this study a suite of models was used to identify predictors of sepsis from 128,799
features distributed among 30,915 unique clinical trials. Thanks to the open-source nature of
machine learning libraries like scikit-learn, and a readiness by the data science and machine
learning community for knowledge transfer, this project has been an illuminating practice in
machine learning applications and platforms for discourse. Though there is no turnkey solution
for health outcome maximization, artificial intelligence and machine learning represent a
tinkerer’s paradise for iterative learning and hypothesis testing that can only make a future
with fewer chronic illnesses more likely.
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